Kebir Sied, Khurshid Zain, Gaertner Florian C, Essler Markus, Hattingen Elke, Fimmers Rolf, Scheffler Björn, Herrlinger Ulrich, Bundschuh Ralph A, Glas Martin
Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Germany.
Stem Cell Pathologies Group, Institute of Reconstructive Neurobiology, University of Bonn Medical Center, Germany.
Oncotarget. 2017 Jan 31;8(5):8294-8304. doi: 10.18632/oncotarget.14166.
Timely detection of pseudoprogression (PSP) is crucial for the management of patients with high-grade glioma (HGG) but remains difficult. Textural features of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (FET-PET) mirror tumor uptake heterogeneity; some of them may be associated with tumor progression.
Fourteen patients with HGG and suspected of PSP underwent FET-PET imaging. A set of 19 conventional and textural FET-PET features were evaluated and subjected to unsupervised consensus clustering. The final diagnosis of true progression vs. PSP was based on follow-up MRI using RANO criteria.
Three robust clusters have been identified based on 10 predominantly textural FET-PET features. None of the patients with PSP fell into cluster 2, which was associated with high values for textural FET-PET markers of uptake heterogeneity. Three out of 4 patients with PSP were assigned to cluster 3 that was largely associated with low values of textural FET-PET features. By comparison, tumor-to-normal brain ratio (TNRmax) at the optimal cutoff 2.1 was less predictive of PSP (negative predictive value 57% for detecting true progression, p=0.07 vs. 75% with cluster 3, p=0.04).
Clustering based on textural O-(2-[18F]fluoroethyl)-L-tyrosine PET features may provide valuable information in assessing the elusive phenomenon of pseudoprogression.
及时检测假性进展(PSP)对于高级别胶质瘤(HGG)患者的管理至关重要,但仍然具有挑战性。O-(2-[18F]氟乙基)-L-酪氨酸正电子发射断层扫描(FET-PET)的纹理特征反映了肿瘤摄取的异质性;其中一些可能与肿瘤进展有关。
14例疑似PSP的HGG患者接受了FET-PET成像。评估了一组19个常规和纹理FET-PET特征,并进行了无监督的一致性聚类。基于RANO标准的随访MRI对真进展与PSP进行最终诊断。
基于10个主要的纹理FET-PET特征识别出了三个稳健的聚类。PSP患者均未归入聚类2,该聚类与摄取异质性的纹理FET-PET标志物的高值相关。4例PSP患者中有3例被归入聚类3,该聚类在很大程度上与纹理FET-PET特征的低值相关。相比之下,最佳截断值为2.1时的肿瘤与正常脑比值(TNRmax)对PSP的预测性较差(检测真进展的阴性预测值为57%,p = 0.07;而聚类3为75%,p = 0.04)。
基于纹理O-(2-[18F]氟乙基)-L-酪氨酸PET特征的聚类可能为评估难以捉摸的假性进展现象提供有价值的信息。